References
- Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, et al. A primer of amyloid nomenclature. Amyloid 2007;14:179–83
- Schonland SO, Hegenbart U, Bochtler T, Mangatter A, Hansberg M, Ho AD, Lohse P, Röcken C. Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. Blood 2012;119:488–93
- Picken MM, Linke RP. Nephrotic syndrome due to an amyloidogenic mutation in fibrinogen A alpha chain. J Am Soc Nephrol 2009;20:1681–5
- Picken MM. Fibrinogen amyloidosis: the clot thickens! Blood 2010;115:2985–6
- Sakuma TH, Hans-Filho G, Arita K, Odashiro M, Odashiro DN, Hans NR, Hans-Neto G, McGrath JA. Familial primary localized cutaneous amyloidosis in Brazil. Arch Dermatol 2009;145:695–9
- Benson MD, Dwulet FE, Scheinberg MA, Greipp P. Chemical classification of hereditary amyloidosis in Brazilian families and identification of gene carriers. J Rheumatol 1986;13:927–31
- Palacios SA, Bittencourt PL, Cancado EL, Farias AQ, Massarollo PC, Mies S, Kalil J, Goldberg AC. Familial amyloidotic polyneuropathy type 1 in Brazil is associated with the transthyretin Val30Met variant. Amyloid 1999;6:289–91
- Alambert CO, Sarpi MO, Dedivitis RA, Alambert PA, Sementilli Â, Arantes LP. Macroglossia como primeira manifestação clínica da amiloidose primária. Rev Bras Reumatol 2007;47:76–9
- Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 2012;19:167–70
- Benson MD, Liepnieks J, Uemichi T, Wheeler G, Correa R. Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain. Nat Genet 1993;3:252–5
- Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005;3:1894–904
- Stangou AJ, Banner NR, Hendry BM, Rela M, Portmann B, Wendon J, Monaghan M, et al. Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood 2010;115:2998–3007
- Kang HG, Bybee A, Ha IS, Park MS, Gilbertson JA, Cheong HI, Choi Y, Hawkins PN. Hereditary amyloidosis in early childhood associated with a novel insertion-deletion (indel) in the fibrinogen Aalpha chain gene. Kidney Int 2005;68:1994–8
- Eriksson M, Schonland S, Bergner R, Hegenbart U, Lohse P, Schmidt H, Rocken C. Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutation. Virchows Arch 2008;453:25–31
- Charlinski G, Wiater E, Jedrzejczak WW. [Immunomodulatory drugs in the treatment of primary systemic light chain amyloidosis]. Pol Merkur Lekarski 2012;32:217–20
- Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002;346:1786–91